Mtb ATP synthase-IN-1（Cat No.:I043681）is a small molecule inhibitor designed to target the ATP synthase enzyme in Mycobacterium tuberculosis (Mtb), the bacterium responsible for tuberculosis (TB). ATP synthase is essential for bacterial energy production, and by inhibiting this enzyme, Mtb ATP synthase-IN-1 disrupts the bacterium’s ability to generate ATP, leading to reduced survival and growth. This compound is being explored in preclinical studies as a potential therapeutic for tuberculosis, aiming to combat antibiotic-resistant strains of Mtb and improve treatment efficacy by targeting a critical metabolic pathway in the bacteria.